Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma
This phase 2 nonrandomized clinical trial assesses the efficacy and safety of dual immune checkpoint inhibition in patients with aggressive thyroid carcinoma.
This phase 2 nonrandomized clinical trial assesses the efficacy and safety of dual immune checkpoint inhibition in patients with aggressive thyroid carcinoma.
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Discover the connection between alcohol consumption and elevated cancer risk.
Examine your skin head-to-toe every month. Self-exams are a simple, powerful way to detect skin cancer early. It could save your life. Learn how.
This systematic review evaluates the quality of mortality prediction models for people with kidney failure and assesses their usefulness in clinical practice.
This cohort study investigates the association between prenatal exposure to systemic glucocorticoids and mental disorders in offspring at the age of 15 years in Denmark.
The ASCO Journals Editorial Fellowship is designed to introduce oncology fellows (or their local equivalent) to the peer review, editing, and publishing of medical research…
CD4+ MMUDLI treatment achieved complete remission rates of more than 50% in treatment-refractory myelodysplastic syndrome.
This cross-sectional study describes the staging information obtained by prostate-specific membrane antigen–positron emission tomography/computed tomography (PSMA-PET/CT) among a patient cohort with high-risk biochemically recurrent prostate…
This cohort study develops case definitions for transgender men and women and compares their validity with the reference standard of self-reported gender identity among individuals…
This cross-sectional study examines whether experiencing high levels of racial segregation in school is associated with cognition and dementia among older Black and White adults.